Qiang Chen, Ph.D. currently is Quality Product Leader at Genentech, Inc., a member of

Roche Group. He serves as the end-to-end quality oversight of several small molecule clinical

development projects. Dr. Chen has 18 years of industrial experience in the areas of

pharmaceutical development, medical device, combination products for both traditional dosage

forms and innovative delivery technology. Prior to joining Genentech, Inc., Dr. Chen served for

several companies in Bay Area mainly in Quality and Analytical Sciences. Dr. Chen was

Director of Analytical Development at Allergan (2012-2013), Senior Director of Quality Control

at Alexza Pharmaceuticals, Inc. (2004-2011), Senior Scientist at Corium International (2002-

2004), Sr. Manager of Analytical Sciences at Cygnus Inc. (1997-2002). Dr. Chen also served as

President of United Chinese University Association in 2013, and has served as President of

Xiamen University Alumni Association in Silicon Valley since 2010. Dr. Chen completed his

undergraduate and graduate from Xiamen University and taught analytical chemistry for 6 years

at Xiamen University before coming to the US pursuing his PhD degree. Dr. Chen received his

PhD degree from New Mexico State University in 1995. He then conducted post-doctoral

research in biosensor development with Dr. Adam Heller at University of Texas at Austin

between 1995 and 1997.